“…CS is the leading cause of hospital mortality associated with acute myocardial infarction (MI). Prevalence of CS due to acute MI varies from 5 to 15% [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 ], although some of these data come from studies performed before the generalization of reperfusion [ 1 , 2 ]. Despite recent advances in the prevention and management of acute MI, and the widespread use of primary percutaneous coronary intervention in patients with ST-elevation MI (STEMI), acute phase mortality of STEMI-complicated CS (STEMI-CS) remains unacceptably high [ 6 , 7 , 8 , 9 , 10 , 11 ].…”